RTA Laboratuvarlari (Turkey) Performance
| RTALB Stock | TRY 12.91 0.01 0.08% |
The company owns a Beta (Systematic Risk) of -0.73, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning RTA Laboratuvarlari are expected to decrease at a much lower rate. During the bear market, RTA Laboratuvarlari is likely to outperform the market. RTA Laboratuvarlari has an expected return of -0.17%. Please make sure to check RTA Laboratuvarlari Biyolojik skewness, day typical price, and the relationship between the maximum drawdown and daily balance of power , to decide if RTA Laboratuvarlari performance from the past will be repeated at future time.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days RTA Laboratuvarlari Biyolojik has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Stock's fundamental drivers remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders. ...more
| Begin Period Cash Flow | 17.5 M | |
| Total Cashflows From Investing Activities | -4.6 M |
RTA |
RTA Laboratuvarlari Relative Risk vs. Return Landscape
If you would invest 1,462 in RTA Laboratuvarlari Biyolojik on January 30, 2024 and sell it today you would lose (171.00) from holding RTA Laboratuvarlari Biyolojik or give up 11.7% of portfolio value over 90 days. RTA Laboratuvarlari Biyolojik is generating negative expected returns and assumes 2.6901% volatility on return distribution over the 90 days horizon. Simply put, 23% of stocks are less volatile than RTA, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
RTA Laboratuvarlari Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for RTA Laboratuvarlari's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as RTA Laboratuvarlari Biyolojik, and traders can use it to determine the average amount a RTA Laboratuvarlari's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0626
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RTALB |
Estimated Market Risk
| 2.69 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average RTA Laboratuvarlari is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of RTA Laboratuvarlari by adding RTA Laboratuvarlari to a well-diversified portfolio.
RTA Laboratuvarlari Fundamentals Growth
RTA Stock prices reflect investors' perceptions of the future prospects and financial health of RTA Laboratuvarlari, and RTA Laboratuvarlari fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on RTA Stock performance.
| Return On Equity | 0.52 | |||
| Return On Asset | 0.0138 | |||
| Profit Margin | 1.10 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 1.27 B | |||
| Shares Outstanding | 100 M | |||
| Price To Earning | 5.85 X | |||
| Price To Book | 2.44 X | |||
| Price To Sales | 6.09 X | |||
| Revenue | 384.34 M | |||
| EBITDA | 171.39 M | |||
| Cash And Equivalents | 71.88 M | |||
| Cash Per Share | 0.72 X | |||
| Total Debt | 307.94 K | |||
| Debt To Equity | 0.15 % | |||
| Book Value Per Share | 5.22 X | |||
| Cash Flow From Operations | 68.78 M | |||
| Earnings Per Share | 2.08 X | |||
| Total Asset | 552.4 M | |||
| Retained Earnings | 26 M | |||
| Current Asset | 39 M | |||
| Current Liabilities | 11 M | |||
About RTA Laboratuvarlari Performance
To evaluate RTA Laboratuvarlari Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when RTA Laboratuvarlari generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare RTA Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand RTA Laboratuvarlari market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents RTA's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. The company was founded in 1996 and is based in Kocaeli, Turkey. RTA LABORATUVARLARI operates under Biotechnology classification in Turkey and is traded on Istanbul Stock Exchange. It employs 100 people.Things to note about RTA Laboratuvarlari performance evaluation
Checking the ongoing alerts about RTA Laboratuvarlari for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for RTA Laboratuvarlari help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| RTA Laboratuvarlari generated a negative expected return over the last 90 days | |
| About 29.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing RTA Laboratuvarlari's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether RTA Laboratuvarlari's stock is overvalued or undervalued compared to its peers.
- Examining RTA Laboratuvarlari's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating RTA Laboratuvarlari's management team can have a significant impact on its success or failure. Reviewing the track record and experience of RTA Laboratuvarlari's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of RTA Laboratuvarlari's stock. These opinions can provide insight into RTA Laboratuvarlari's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RTA Laboratuvarlari Biyolojik. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the RTA Laboratuvarlari information on this page should be used as a complementary analysis to other RTA Laboratuvarlari's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for RTA Stock analysis
When running RTA Laboratuvarlari's price analysis, check to measure RTA Laboratuvarlari's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RTA Laboratuvarlari is operating at the current time. Most of RTA Laboratuvarlari's value examination focuses on studying past and present price action to predict the probability of RTA Laboratuvarlari's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RTA Laboratuvarlari's price. Additionally, you may evaluate how the addition of RTA Laboratuvarlari to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |